Showing results (11-20 of 116) with videos related to
Sort By:
Pageof 12
Blood|December 31, 2002
Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesionPatrick C Hines, Qin Zen, Sharran N Burney, et al.The American Journal of Medicine|October 27, 2004
Pulmonary hypertension in sickle cell diseaseKenneth I Ataga, Namita Sood, Guy De Gent, et al.Blood|December 31, 2009
Placenta growth factor in sickle cell disease: association with hemolysis and inflammationJulia E Brittain, Ben Hulkower, Susan K Jones, et al.European Journal of Haematology|May 25, 2010
Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1Kenneth I Ataga, Julia E Brittain, Dominic Moore, et al.Expert Opinion on Investigational Drugs|February 25, 2009
Senicapoc (ICA-17043): a potential therapy for the prevention and treatment of hemolysis-associated complications in sickle cell anemiaKenneth I Ataga, Jonathan StockerF1000Research|August 9, 2020
Drug Therapies for the Management of Sickle Cell DiseaseParul Rai, Kenneth I AtagaBritish Journal of Haematology|July 1, 2015
The trials and hopes for drug development in sickle cell diseaseKenneth I Ataga, Jonathan StockerHaematologica|January 2, 2008
Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertensionKenneth I Ataga, Charity G Moore, Cheryl A Hillery, et al.British Journal of Haematology|January 13, 2011
Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell diseaseKenneth I Ataga, Julia E Brittain, Susan K Jones, et al.Hematology. American Society of Hematology. Education Program|December 9, 2023
Using disease-modifying therapies in sickle cell diseaseParul Rai, Kenneth I AtagaPageof 12